These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16781374

  • 1. Beta-blocker use and outcomes among hospitalized heart failure patients.
    Butler J, Young JB, Abraham WT, Bourge RC, Adams KF, Clare R, O'Connor C, ESCAPE Investigators.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2462-9. PubMed ID: 16781374
    [Abstract] [Full Text] [Related]

  • 2. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Coordinators.
    J Card Fail; 2007 Nov 20; 13(9):722-31. PubMed ID: 17996820
    [Abstract] [Full Text] [Related]

  • 3. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.
    Am Heart J; 2008 Oct 20; 156(4):662-73. PubMed ID: 18926148
    [Abstract] [Full Text] [Related]

  • 4. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M.
    Am J Cardiol; 2008 Dec 15; 102(12):1711-7. PubMed ID: 19064029
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J.
    Am Heart J; 2004 Jul 15; 148(1):43-51. PubMed ID: 15215791
    [Abstract] [Full Text] [Related]

  • 11. Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure.
    Parameswaran AC, Tang WH, Francis GS, Gupta R, Young JB.
    Am Heart J; 2005 May 15; 149(5):921-6. PubMed ID: 15894978
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.
    Patel P, White DL, Deswal A.
    Am Heart J; 2007 Apr 15; 153(4):515-22. PubMed ID: 17383287
    [Abstract] [Full Text] [Related]

  • 15. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lappé DL, Jensen KR, Horne BD, Carter MA, Anderson JL, Intermountain Heart Collaborative Study Group.
    Am J Cardiol; 2005 Apr 01; 95(7):827-31. PubMed ID: 15781009
    [Abstract] [Full Text] [Related]

  • 16. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J, HELUMA study group.
    Eur Heart J; 2005 Dec 01; 26(24):2689-97. PubMed ID: 16183697
    [Abstract] [Full Text] [Related]

  • 17. B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.
    Jondeau G, Neuder Y, Eicher JC, Jourdain P, Fauveau E, Galinier M, Jegou A, Bauer F, Trochu JN, Bouzamondo A, Tanguy ML, Lechat P, B-CONVINCED Investigators.
    Eur Heart J; 2009 Sep 01; 30(18):2186-92. PubMed ID: 19717851
    [Abstract] [Full Text] [Related]

  • 18. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.
    Chan AY, McAlister FA, Norris CM, Johnstone D, Bakal JA, Ross DB, Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators.
    J Thorac Cardiovasc Surg; 2010 Jul 01; 140(1):182-7, 187.e1. PubMed ID: 20427056
    [Abstract] [Full Text] [Related]

  • 19. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
    Dhaliwal AS, Habib G, Deswal A, Verduzco M, Souchek J, Ramasubbu K, Aguilar D, Ma TS, Jneid HM, Bolos M, Bozkurt B.
    Am J Cardiol; 2009 Jul 15; 104(2):270-5. PubMed ID: 19576359
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.